Cargando…
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
The status of Fas and Fas ligand (Fas L) expression was investigated in this study for 103 hepatocellular carcinomas (HCC). We studied the expression of the following three factors, Fas and Fas L expression in carcinoma cells and Fas L expression in stromal mononuclear cells (defined as stromal Fas...
Autores principales: | Ito, Y, Monden, M, Takeda, T, Eguchi, H, Umeshita, K, Nagano, H, Nakamori, S, Dono, K, Sakon, M, Nakamura, M, Tsujimoto, M, Nakahara, M, Nakao, K, Yokosaki, Y, Matsuura, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363358/ https://www.ncbi.nlm.nih.gov/pubmed/10735508 http://dx.doi.org/10.1054/bjoc.1999.1065 |
Ejemplares similares
-
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (1999) -
Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms
por: Munakata*, S, et al.
Publicado: (2000) -
Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells
por: Ragnarsson, G B, et al.
Publicado: (2000) -
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2001) -
Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR
por: Das, H, et al.
Publicado: (2000)